Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return
暂无分享,去创建一个
[1] U. B. Olsen,et al. N″-cyano-N-4-pyridyl-N′-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): A new, potent vasodilator , 1980, Experientia.
[2] Y. Imai,et al. Role of the Peripheral Vasculature in Changes in Venous Return Caused by Isoproterenol, Norepinephrine, and Methoxamine in Anesthetized Dogs , 1978, Circulation Research.
[3] L. Opie. Calcium channel antagonists part IV: Side effects and contraindications drug interactions and combinations , 1988, Cardiovascular Drugs and Therapy.
[4] N. Taira,et al. Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery , 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.
[5] T. Yanagisawa,et al. Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog , 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.
[6] T. Yanagisawa,et al. The negative inotropic effect of nicorandil is independent of cyclic GMP changes: a comparison with pinacidil and cromakalim in canine atrial muscle , 1988, British journal of pharmacology.
[7] N. Taira,et al. Is the Cardiovascular Profile of BRL 34915 Characteristic of Potassium Channel Activators? , 1988, Journal of Cardiovascular Pharmacology.
[8] C. Pally,et al. Similarities in the Mechanism of Action of Two New Vasodilator Drugs: Pinacidil and BRL 34915 , 1988, Journal of cardiovascular pharmacology.
[9] N. Taira,et al. Pinacidil increases the background potassium current in single ventricular cells. , 1987, European journal of pharmacology.
[10] Kenzo Takahashi,et al. Effect of DHP‐218, a Novel Dihydropyridine Phosphonate, on Atrioventricular Nodal Conductivity Compared with Its Vascular Effect in Dogs , 1987, Journal of Cardiovascular Pharmacology.
[11] A. Weston,et al. New class of antihypertensive acts by opening K+ channels , 1987 .
[12] N. Taira,et al. Differences in cardiovascular profile among calcium antagonists. , 1987, The American journal of cardiology.
[13] N. Taira. Similarity and Dissimilarity in the Mode and Mechanism of Action Between Nicorandil and Classical Nitrates: An Overview , 1987, Journal of cardiovascular pharmacology.
[14] T. Aizawa,et al. Effects of Nicorandil on Coronary Circulation in Patients with Ischemic Heart Disease: Comparison with Nitroglycerin , 1987, Journal of Cardiovascular Pharmacology.
[15] A. Weston,et al. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels , 1986, British journal of pharmacology.
[16] J. Clapham,et al. BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. , 1986, Journal of cardiovascular pharmacology.
[17] S. Holzmann. Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG‐75) , 1983, Journal of cardiovascular pharmacology.
[18] T. Itoh,et al. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. , 1981, The Journal of pharmacology and experimental therapeutics.
[19] 柳澤 輝行. Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog : increase in potassium conductance , 1980 .
[20] Y. Imai,et al. Differential effects of nitroglycerin, trimetazidine, verapamil and SK&F 24260 on venous return as revealed by the open-loop method in the dog. , 1980, Japanese journal of pharmacology.
[21] Y. Imai,et al. PHARMACOLOGICAL PROFILE OF A NEW CORONARY VASODILATOR DRUG, 2‐NICOTINAMIDOETHYL NITRATE (SG‐75) , 1979, Clinical and experimental pharmacology & physiology.
[22] T. Yanagisawa,et al. Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75). , 1979, Japanese journal of pharmacology.
[23] E. Arrigoni-Martelli,et al. SYNTHESIS AND HYPOTENSIVE ACTIVITY OF N-ALKYL-N′′-CYANO-N′-PYRIDYLGUANIDINES , 1978 .
[24] Y. Imai,et al. Role of the Peripheral Vasculature in Changes in Venous Return Caused by Isoproterenol, Norepinephrine, and Methoxamine in Anesthetized Dogs , 1978, Circulation research.
[25] E. Arrigoni-Martelli,et al. Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines. , 1978, Journal of medicinal chemistry.
[26] Y. Uchida,et al. Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation. , 1978, Japanese heart journal.
[27] Y. Imai,et al. Cardiohemodynamic effects of SK&F 24260, D 600, diltiazem, dilazep, and trimetazidine in the dog. , 1977, Japanese heart journal.
[28] N. Taira,et al. Cardiohemodynamic effects of nitroglycerin and several vasodilators. , 1974, Japanese heart journal.
[29] W. Lochner,et al. Effects of nitroglycerin, dipyridamole, carbocromen, xanthinol nicotinate, and butallylonal on venous return. , 1972, Arzneimittel-Forschung.
[30] J. Ross,et al. ALPHA AND BETA ADRENERGIC RECEPTOR MECHANISMS IN THE SYSTEMIC VENOUS BED. , 1964, The Journal of pharmacology and experimental therapeutics.
[31] W. D. Halliburton,et al. Handbook of Physiology , 1870, Edinburgh Medical Journal.